Merck KGaA (MKGAF)
OTCMKTS · Delayed Price · Currency is USD
136.74
-5.67 (-3.98%)
Dec 12, 2025, 3:53 PM EST
Merck KGaA Market Cap
Merck KGaA has a market cap or net worth of $60.15 billion as of December 15, 2025. Its market cap has decreased by -7.58% in one year.
Market Cap
60.15B
Enterprise Value
71.00B
Revenue
24.96B
Ranking
n/a
PE Ratio
17.34
Stock Price
$136.74
Market Cap Chart
Since April 7, 1997, Merck KGaA's market cap has increased from 6.76B to 60.15B, an increase of 789.42%. That is a compound annual growth rate of 7.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 60.52B | -4.11% |
| Dec 30, 2024 | 63.11B | -8.87% |
| Dec 29, 2023 | 69.25B | -17.61% |
| Dec 30, 2022 | 84.06B | -24.78% |
| Dec 30, 2021 | 111.75B | 49.03% |
| Dec 30, 2020 | 74.98B | 45.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 841.30M |
| Glass House Brands | 743.26M |
| Elite Pharmaceuticals | 537.17M |
| CytoDyn | 407.36M |
| Northwest Biotherapeutics | 368.73M |
| American Oncology Network | 365.47M |
| Silence Therapeutics | 298.52M |
| Nika Pharmaceuticals | 291.10M |